Ask Warren

Nextbiomedical

389650 · KOSDAQ · ₩389650 · 넥스트바이오메디컬

₩27,150▼ ₩1,200 (4.23%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Revenue₩4.9B₩4.1B₩3.8B₩4.9B₩4B₩3.8B₩2.2B
Cost of sales₩1.4B₩1.3B₩1.1B₩1.4B₩1.1B₩1.3B₩912M
Gross profit₩3.5B₩2.8B₩2.7B₩3.6B₩2.8B₩2.4B₩1.3B
Operating income−₩1B−₩1.2B−₩442M₩370M₩21M−₩668M−₩1.1B
Net income−₩487M−₩146M−₩1.4B₩2B−₩481M−₩421M₩4.2B
Net income to shareholders−₩487M−₩146M−₩1.4B₩2B−₩481M−₩421M₩4.2B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Total assets₩64B₩60B₩59B₩58B₩59B₩59B₩59B
Current assets₩44B₩41B₩43B₩35B₩37B₩47B₩47B
Cash and equivalents₩14B₩4B₩6.8B₩5.8B₩4.1B₩5.8B₩5B
Total liabilities₩14B₩11B₩11B₩12B₩14B₩14B₩14B
Current liabilities₩8.8B₩8B₩8B₩9.5B₩12B₩12B₩12B
Borrowings₩639M₩774M₩951M₩1.1B₩1.3B₩722M₩764M
Total equity₩49B₩49B₩48B₩46B₩45B₩45B₩45B
Shareholders' equity₩49B₩49B₩48B₩46B₩45B₩45B₩45B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Cash from operations₩215M−₩694M₩1.3B−₩9.2M−₩270M₩198M−₩910M
Capital spending₩119M₩47M₩308M₩549M₩2.2B₩128M₩248M
Free cash flow₩96M−₩741M₩1B−₩558M−₩2.4B₩70M−₩1.2B

Consolidated where available. Amounts in won.

Also known as: Nextbiomedical / 넥스트바이오메디컬 / 389650 / KRX:389650

Source: KRX statistical information